VAERS reports by lot

GSK Varicella/Shingles lot C523T: VAERS reports

112 VAERS reports list lot C523T as a GSK Varicella/Shingles vaccine, received between 2018-04-06 and 2019-07-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
112
Reports
4%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction11930%
General / Systemic (non-local)9323%
Dermatological (non-injection-site)5213%
Musculoskeletal4110%
Neurological277%
Allergic / Anaphylactic205%
Cardiac / Cardiovascular144%
Gastrointestinal144%
Respiratory82%
Psychiatric / Neuropsychiatric51%
Thrombotic / Hematological41%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California12
Pennsylvania9
Texas7
Washington7
Virginia5
Michigan5
New York4
Massachusetts3
Wisconsin3
Minnesota3
Montana3
Maine3

Reports by month received

2018-0440
2018-0535
2018-0613
2018-079
2018-086
2018-092
2018-103
2018-111
2019-011
2019-072

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.